Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCOX: BAT1306 and COX Inhibitor in MSI-H/dMMR Colorectal Cancer
NCT03638297Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2018
- Primary completion
- Aug 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of bat1306 in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
bat1306
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03638297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03638297.